Cemsidomide clinical trials

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma (r/r MM)

This study is looking at a new drug, cemsidomide, combined with an existing treatment, dexamethasone, for people with multiple myeloma that has come back or not responded to previous treatments. Researchers want to see how well this new combination works.